Treatment of acute dyspnea with morphine to avert respiratory failure

Annals of the American Thoracic Society

Volumn 14, Issue 4, 2017, Pages 584-588

  Soffler, Morgan I ^a   Rose, Alexandra ^b   Hayes, Margaret M ^c,d   Banzett, Robert ^c,d   Schwartzstein, Richard M ^c,d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BRONCHODILATING AGENT; MORPHINE; OXYGEN;

ABDOMINAL PAIN; AGED; ANOREXIA; ANTIBIOTIC THERAPY; ASTHMA; BRONCHOCONSTRICTION; BRONCHOSPASM; CASE REPORT; DYSPNEA; ECHOGRAPHY; ELECTROCARDIOGRAPHY; ENDOTRACHEAL INTUBATION; EXPIRATORY FLOW; FEMALE; FEVER; GASTROESOPHAGEAL REFLUX; HUMAN; HYPERINFLATION; IMAGE GUIDED BIOPSY; LIVER BIOPSY; LUNG AUSCULTATION; LUNG FUNCTION TEST; MEDICAL HISTORY; NOTE; OXYGEN NASAL CANNULA; OXYGEN SATURATION; OXYGEN THERAPY; RESPIRATORY DISTRESS; RESPIRATORY FAILURE; SINUS TACHYCARDIA; TACHYCARDIA; TACHYPNEA; THORAX RADIOGRAPHY; VITAL SIGN; WHEEZING; ADULT RESPIRATORY DISTRESS SYNDROME; ANXIETY; CLINICAL OBSERVATION; CLINICAL STUDY; DIAGNOSIS; PATHOPHYSIOLOGY; PSYCHOLOGY;

AGED; ANXIETY; DYSPNEA; FEMALE; HUMANS; MORPHINE; RESPIRATORY DISTRESS SYNDROME, ADULT; RESPIRATORY INSUFFICIENCY;

EID: 85017255109     PISSN: 23256621     EISSN: None     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201611-922CC     Document Type: Note

References (11)

1. Hyatt RE, Wilson TA. Forced Expiration. In: Crystal R, editor. The Lung. Philadelphia: Lippincott-Raven Publishers; 1997. pp. 1393-1401.
2. Schwartzstein RM, Parker MJ. Respiratory physiology: A clinical approach. Baltimore, MD: Lippincott Williams & Wilkins, 2006.
3. Parshall MB, Schwartzstein RM, Adams L, Banzett RB, Manning HL, Bourbeau J, Calverley PM, Gift AG, Harver A, Lareau SC, et al. ; American Thoracic Society Committee on Dyspnea. An official American Thoracic Society statement: Update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med 2012;185:435-452.
4. Schwartzstein RM, Manning HL, Weiss JW, Weinberger SE. Dyspnea: A sensory experience. Lung 1990;168:185-199.
5. Yorke J, Moosavi SH, Shuldham C, Jones PW. Quantification of dyspnoea using descriptors: Development and initial testing of the Dyspnoea-12. Thorax 2010;65:21-26.
6. Banzett RB, O'Donnell CR, Guilfoyle TE, Parshall MB, Schwartzstein RM, Meek PM, Gracely RH, Lansing RW. Multidimensional Dyspnea Profile: An instrument for clinical and laboratory research. Eur Respir J 2015;45:1681-1691.
7. Carrieri-Kohlman V, Gormley JM, Douglas MK, Paul SM, Stulbarg MS. Exercise training decreases dyspnea and the distress and anxiety associated with it. Monitoring alone may be as effective as coaching. Chest 1996;110:1526-1535.
8. Banzett RB, Adams L, O'Donnell CR, Gilman SA, Lansing RW, Schwartzstein RM. Using laboratory models to test treatment: Morphine reduces dyspnea and hypercapnic ventilatory response. Am J Respir Crit Care Med 2011;184:920-927.
9. Pattinson KTS, Governo RJ, MacIntosh BJ, Russell EC, Corfield DR, Tracey I, Wise RG. Opioids depress cortical centers responsible for the volitional control of respiration. J Neurosci 2009;29:8177-8186.
10. Jennings A-L, Davies AN, Higgins JPT, Gibbs JSR, Broadley KE. A systematic review of the use of opioids in the management of dyspnoea. Thorax 2002;57:939-944.
11. Mahler DA. Opioids for refractory dyspnea. Expert Rev Respir Med 2013;7:123-134, quiz 135.